Related Experiment Video
Updated: Nov 8, 2025
09:03
Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
Published on: June 19, 2018
8.9K
[COVID-19 vaccination: the reality after clinical trials]
J Ruiz-Galiana, R Cantón, P De Lucas Ramos
1Servicio de Microbiología Clínica y Enfermedades Infecciosas del Hospital General Universitario Gregorio Marañón, Universidad Complutense. CIBERES. Ciber de Enfermedades Respiratorias. Madrid, Spain. emilio.bouza@gmail.com.
Summary
Real-world data on SARS-CoV-2 vaccination is growing, addressing key questions about vaccine indications, efficacy, and tolerance. This review offers multidisciplinary insights based on current clinical experience outside of trials.
Area of Science:
- Public Health
- Infectious Diseases
- Vaccinology
Background:
- Accumulating real-world clinical experience with SARS-CoV-2 vaccination is providing valuable data beyond initial trial findings.
- Ongoing questions regarding COVID-19 vaccines necessitate a review of current evidence.
- A multidisciplinary approach is crucial for understanding complex vaccination issues.
Purpose of the Study:
- To address pending questions concerning SARS-CoV-2 vaccination using available real-world data.
- To review and discuss the indications, efficacy, and tolerance of anti-COVID-19 vaccines.
- To provide evidence-based answers to common queries about COVID-19 vaccination.
Main Methods:
- Review of accumulating clinical experience and real-world data on SARS-CoV-2 vaccination.
- Multidisciplinary discussion and analysis by the Scientific Committee on COVID-19 of the Madrid College of Physicians.
- Question-and-answer format addressing various aspects of vaccine indications, efficacy, and tolerance.
Main Results:
- Clinical experience is resolving questions about vaccine indications, efficacy, and tolerance.
- Real-world data complements findings from clinical trials.
- The review synthesizes current knowledge on anti-COVID-19 vaccination.
Conclusions:
- Current clinical experience supports the safety and efficacy of SARS-CoV-2 vaccines.
- Further real-world data collection is essential for ongoing vaccine monitoring.
- Multidisciplinary collaboration enhances understanding of vaccination strategies.
Related Concept Videos
01:16Clinical Trials
9.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
9.9K
01:11Clinical Trials: Overview
4.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.1K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
220
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
220
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
41
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
41
01:13Bioequivalence studies: Biowaivers
59
Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
59
01:30Cancer Vaccines
603
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
603